Ascierto PA, Dummer R, Gogas HJ, Arance A, et al. Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial. J Clin Oncol 2023 Jul 28:JCO2202322. doi: 10.1200/JCO.22.02322.
PMID: 37506329